Skip to main content
SpringerLink
Log in

Effect of calcium antagonists on regional cerebral blood flow in transplanted rat brain tumors

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

We studied the effect of intracarotid infusion of various calcium antagonists on regional CBF (rCBF) in the C6 rat glioma by a hydrogen clearance method. Nimodipine at doses of 0.1, 0.5 and 1 μg/kg/min was found to produce tumor-specific increases in the rCBF (40.2 ± 18.4%, p < 0.01, 67.8 ±32.6%, p < 0.001 and 37.3 ±37.2%, p < 0.05, respectively) without affecting systemic blood pressure. Regarding the time course of the nimodipine effects, at a dose of 0.5 μg/kg/min, rCBF in the tumor showed maximum value at fifteen minutes after the start of the intracarotid infusion. Diltiazem at doses of 5, 20, and 40 μg/kg/min also increased tumor rCBF in a dose-dependent manner (27.9 ± 12.5%, p < 0.001, 52.0 ± 21.8%, p -AN 0.001 and 54.5 ± 18.4%, p < 0.001, respectively). Both nifedipine and flunarizine significantly increased the rCBF in the tumor, while they did not cause a higher percent increase of the rCBF when compared with those of nimodipine and diltiazem. No significant percent increase of the rCBF in the tumor was observed in verapamil treated rats. These results indicate that tumor vessels may have an altered response to calcium antagonists, especially to nimodipine and diltiazem, when compared to normal brain capillaries. The varied responses to calcium antagonists could be explained by their differences in tissue selectivity and affinity to calcium channels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CBF:

regional cerebral blood flow

MABP:

mean arterial blood pressure

References

  1. Harper AM, Craigen L, Kazda S: Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate. J Cereb Blood Flow Metab 1: 349–356, 1981.

    Google Scholar 

  2. Saida K, van Breemen C: Mechanism of Ca++ antagonist-induced vasodilation. Intracellular actions. Circ Res 52: 137–142, 1983.

    Google Scholar 

  3. Shimizu K, Ohta T, Toda N: Evidence of greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries. Stroke 11: 261–266, 1980.

    Google Scholar 

  4. van Breemen C, Mangel A, Fahim M, Meisheri K: Selectivity of calcium antagonistic action in vascular smooth muscle. Am J Cardiol 49: 507–510, 1982.

    Google Scholar 

  5. Mohamed AA, Gotoh O, Graham DI, Osborne KA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM: Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18: 705–711, 1985.

    Google Scholar 

  6. Jansen I, Tfelt-Hansen P, Edvinsson L: Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders. Eur J Clin Pharmacol 40: 7–15, 1991.

    Google Scholar 

  7. Toshima M, Kassell NF, Sasaki T, Tanaka Y, Machi T: The effect of hemoglobin on vasodilatory effect of calcium antagonists in the isolated rabbit basilar artery. J Neurosurg 76: 670–678, 1992.

    Google Scholar 

  8. Grabowski M, Johansson BB: Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. J Cardiovasc Pharmacol 7: 1127–1133, 1985.

    Google Scholar 

  9. Hollerhage HG, Gaab MR, Zumkeller M, Walter GF: The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier. J Neurosurg 69: 919–922, 1988.

    Google Scholar 

  10. Steen PA, Newberg LA, Milde JH, Michenfelder JD: Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 3: 38–43, 1983.

    Google Scholar 

  11. Frazee JG, Bevan JA, Bevan RD, Jones KR: Effect of diltiazem on experimental chronic cerebral vasospasm in the monkey. J Neurosurg 62: 912–917, 1985.

    Google Scholar 

  12. De Ley G, Weyne J, Demeester G, Stryckmans K, Goethals P, Leusen I: Streptokinase treatment versus calcium overload blockade in experimental thromboembolic stroke. Stroke 2: 357–361, 1989.

    Google Scholar 

  13. Nishio S, Ohta M, Abe M, Kitamura K: Microvascular abnormalities in ethylnitrosourea (ENU)-induced rat brain tumors: structural basis for altered blood-brain barrier function. Acta Neuropathol 59: 1–10, 1983.

    Google Scholar 

  14. Nishio S, Egami H, Fukui M, Kitamura K, Sawa H: Ultrastructural and cytochemical study of microvascular enzyme activity in experimental brain tumors of rat. Neurol Med Chir 26: 527–533, 1986.

    Google Scholar 

  15. Baba T, Fukui M, Sakata S, Tashima T, Takeshita I, Nakamura T, Inoue T: Selective enhancement of intratumoural blood flow in malignant gliomas: experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate. Acta Neurochir 101: 66–74, 1989.

    Google Scholar 

  16. Baba T, Fukui M, Takeshita I, Ichiya Y, Kuwabara Y, Hasuo K: Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 72: 907–911, 1990.

    Google Scholar 

  17. Natori Y, Moriguchi M, Fujiwara S, Takeshita I, Fukui M, Iwaki T, Kanaide H: Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow. J Cereb Blood Flow Metab 12: 120–127, 1992.

    Google Scholar 

  18. Natori Y, Baba T, Moriguchi M, Takeshita I; Fukui M: Effects of theophylline on the selective increases in intratumoral blood flow induced by intracarotid infusion of adenosine and adenosine triphosphate in C6 glioma-transplanted rat brains. Surg Neurol 37: 8–14, 1992.

    Google Scholar 

  19. Nomura T, Ikezaki K, Matsukado K, Fukui M: Effects of prostacyclin analogue iloprost on the regional cerebral blood flow in transplanted rat brain tumour. Neurol Res 15: 401–404, 1993.

    Google Scholar 

  20. Nomura T, Ikezaki K, Natori Y, Fukui M: Altered response to histamine in brain tumor vessels: the selective increase of regional cerebral blood flow in transplanted rat brain tumor. J Neurosurg 79: 722–728, 1993.

    Google Scholar 

  21. Black KL, Chio CC: Increased opening of blood-tumour barrier by leukotriene C4 is dependent on size of molecules. Neurol Res 14: 402–405, 1992.

    Google Scholar 

  22. Inamura T, Black K: Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 14: 862–870, 1994.

    Google Scholar 

  23. Matsuura H, Ikeda Y, Imaya H, Nakazawa S: Selective change of blood flow in experimental brain tumor with induced hypertension. Surg Neurol 27: 433–436, 1987.

    Google Scholar 

  24. Panther LA, Baumbach GL, Bigner DD, Piegors D, Groothuis DR, Heistad DD: Vasoactive drugs produce selective changes in flow to experimental brain tumors. Ann Neurol 18: 712–715, 1985.

    Google Scholar 

  25. Edvinsson L, Johansson BB, Larsson B, MacKenzie ET, Skarby T, Young AR: Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat. Br J Pharmacol 79: 141–148, 1983.

    Google Scholar 

  26. Aukland K, Bower BF, Berliner RW: Measurement of local blood flow with hydrogen rats. Circ Res 14: 66–74, 1964.

    Google Scholar 

  27. Hugenholtz PG, Michels HR, Serruys PW, Boower RW: Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am J Cardiol 47: 163–173, 1981.

    Google Scholar 

  28. Guazzi MD, Polese A, Fiorentini C, Bartorelli A, Moruzzi P: Treatment of hypertension with calcium antagonists. Review Hypertension 5:II85–90, 1983.

    Google Scholar 

  29. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR: Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308: 619–624, 1983.

    Google Scholar 

  30. Steen PA, Gisvold SE, Milde JH, Newberg LA, Scheithauer BW, Lanier WL, Michenfelder JD: Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 62: 406–414, 1985.

    Google Scholar 

  31. Harris RJ, Branston NM, Symon L, Bayhan M, Watson A: The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13: 759–766, 1982.

    Google Scholar 

  32. Forsman M, Fleischer JE, Milde JH, Steen PA, Michenfelder JD: The effects of nimodipine on cerebral blood flow and metabolism. J Cereb Blood Flow Metab 6: 763–767, 1986.

    Google Scholar 

  33. Janicki PK, Siembab D, Paulo EA, Krzascik P: Single-dose kinetics of nifedipine in rat plasma and brain. Pharmacology 36: 183–187, 1988.

    Google Scholar 

  34. Heffez DS, Nowak T Jr., Passonneau JV Nimodipine levels in gerbil brain following parenteral drug administration. J Neurosurg 63: 589–592, 1985.

    Google Scholar 

  35. Andersson KE, Edvinsson L, MacKenzie ET, Skarby T, Young AR: Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the rat. Br J Pharmacol 79: 135–140, 1983.

    Google Scholar 

  36. Bevan JA: Selective action of diltiazem on cerebral vascular smooth muscle in the rabbit: antagonism of extrinsic but not intrinsic maintained tone. Am J Cardiol 49: 519–524, 1982.

    Google Scholar 

  37. Pearce WJ, Bevan JA: Diltiazem and autoregulation of canine cerebral blood flow. J Pharmacol Exp Ther 242: 812–817, 1987.

    Google Scholar 

  38. Lugnier C, Follenius A, Gerard D, Stoclet JC: Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol 98: 157–158, 1984.

    Google Scholar 

  39. Descombes JJ, Stoclet JC: Diphenylalkylamine calcium antagonists interact with alpha-adrenoceptor binding sites in aortic membranes. Eur J Pharmacol 115: 313–316, 1985.

    Google Scholar 

  40. DePover A, Matlib MA, Lee SW, Dube GP, Grupp IL, Grupp G, Schwartz A: Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun 108: 110–117, 1982.

    Google Scholar 

  41. Ehlert FJ, Itoga E, Roeske WR, Yamamura HI: The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Commun 104: 937–943, 1982.

    Google Scholar 

  42. Murphy KM, Snyder SH: Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. J Cereb Blood Flow Metab 4: 201–202, 1984.

    Google Scholar 

  43. Johansson BB: The blood-brain barrier in acute and chronic hypertension. Adv Exp Med Biol 131: 211–226, 1980.

    Google Scholar 

  44. Matsukado K, Nomura T, Ikezaki K, Fukui M: Selective increase in blood-tumor barrier permeability by calcium antagonists in transplanted rat brain tumors. Acta Neurochir Suppl 60: 403–405, 1994.

    Google Scholar 

  45. Black KL, King WA, Ikezaki K: Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg 72: 912–916, 1990.

    Google Scholar 

  46. Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13: 70–82, 1986.

    Google Scholar 

  47. Levin VA: A pharmacologic basis for brain tumor chemotherapy. Semin Oncol 2: 57–61, 1975.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan

    Koichiro Matsukado, Kiyonobu Ikezaki, Tomojiro Nomura & Masashi Fukui

Authors
  1. Koichiro Matsukado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiyonobu Ikezaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomojiro Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masashi Fukui
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsukado, K., Ikezaki, K., Nomura, T. et al. Effect of calcium antagonists on regional cerebral blood flow in transplanted rat brain tumors. J Neuro-Oncol 27, 1–10 (1996). https://doi.org/10.1007/BF00146078

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00146078

Key words

Search

Navigation